PBE Holdings List

As of May 2, 2025

No.	Symbol	Name	% Weight	Shares
1	NTRA	Natera, Inc.	5.34%	75,925
2	NBIX	Neurocrine Biosciences, Inc.	5.03%	102,195
3	GILD	Gilead Sciences, Inc.	4.94%	106,203
4	AMGN	Amgen Inc.	4.74%	37,524
5	BIIB	Biogen Inc.	4.58%	82,559
6	REGN	Regeneron Pharmaceuticals, Inc.	4.45%	16,373
7	UTHR	United Therapeutics Corporation	4.38%	33,135
8	ILMN	Illumina, Inc.	4.33%	123,695
9	TGTX	TG Therapeutics, Inc.	4.31%	221,180
10	PTGX	Protagonist Therapeutics, Inc.	3.76%	184,113
11	CPRX	Catalyst Pharmaceuticals, Inc.	3.46%	310,607
12	BPMC	Blueprint Medicines Corporation	3.33%	70,799
13	QGEN	Qiagen N.V.	3.15%	162,590
14	BCRX	BioCryst Pharmaceuticals, Inc.	3.13%	779,510
15	EXEL	Exelixis, Inc.	3.11%	174,838
16	HALO	Halozyme Therapeutics, Inc.	3.06%	111,408
17	EXAS	Exact Sciences Corporation	2.98%	128,620
18	PTCT	PTC Therapeutics, Inc.	2.88%	128,294
19	RPRX	Royalty Pharma plc	2.83%	191,591
20	COLL	Collegium Pharmaceutical, Inc.	2.78%	224,177
21	VCYT	Veracyte, Inc.	2.63%	192,906
22	MNKD	MannKind Corporation	2.56%	1,142,366
23	BMRN	BioMarin Pharmaceutical Inc.	2.53%	90,700
24	DVAX	Dynavax Technologies Corporation	2.45%	481,349
25	INCY	Incyte Corporation	2.44%	86,742
26	TECH	Bio-Techne Corporation	2.28%	100,507
27	ACAD	ACADIA Pharmaceuticals Inc.	2.27%	339,519
28	XNCR	Xencor, Inc.	2.26%	446,673
29	CDNA	CareDx, Inc	2.08%	308,964
30	MYGN	Myriad Genetics, Inc.	1.87%	549,717
31	AGPXX	Short-Term Investment Trust - Invesco Government & Agency Portfolio	0.06%	139,198
32	n/a	Cash	0.00%	5,728
33	n/a	Securities Lending - Bnym	0.00%	1

As of May 2, 2025